Figure 9. Pyrvinium pamoate dose-dependently inhibits tumor-sphere formation in MCF7 and T47D cells, two commonly used ER(+) breast cancer cell lines.

Pyrvinium pamoate was initially tested over the range of 1 nM to 500 nM. Note that 250 nM and 500 nM were the most effective. (*)p <0.001.